| Mepha Pharma AG - Mirtazapin-Mepha Teva 30 mg, Filmtabletten | | 61460 | | 02 | | Mirtazapin-Mepha Teva 30 mg | | Filmtabletten | | N06AX11 | | Mirtazapin | | 06.09.2011 | | |
| | Composition | | mirtazapinum 30 mg, lactosum monohydricum 203.6 mg, amylum pregelificatum, silica colloidalis anhydrica, carmellosum natricum conexum corresp. natrium max. 0.52 mg, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 8000, E 172 (flavum), E 172 (rubrum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. |
|---|
| Mirtazapine | 30 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Rubrum) | | | | Amylum Pregelificatum | | | | Carmellosum Natricum Conexum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 203.6 mg | | | Macrogol | 8000 | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | |
|
| |
|
